Primecap Management Portfolio holdings
AUM
$126B
This Quarter Return
+12.35%
1 Year Return
+17.42%
3 Year Return
+102.42%
5 Year Return
+196.08%
10 Year Return
+554.06%
AUM
$136B
AUM Growth
+$136B
(+10%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
28.12%
Holding
295
New
4
Increased
72
Reduced
149
Closed
3
Top Buys
| 1 |
Elanco Animal Health
ELAN
|
$822M |
| 2 |
Bristol-Myers Squibb
BMY
|
$151M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
$98.9M |
| 4 |
Novartis
NVS
|
$93.3M |
| 5 |
CVS Health
CVS
|
$77M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$956M |
| 2 |
NVIDIA
NVDA
|
$296M |
| 3 |
Amgen
AMGN
|
$155M |
| 4 |
Cisco
CSCO
|
$153M |
| 5 |
Adobe
ADBE
|
$139M |
Sector Composition
| 1 | Technology | 30.2% |
| 2 | Healthcare | 24.5% |
| 3 | Industrials | 15.11% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Financials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Celanese
CE
$5.22B
| $1.08M | ﹤0.01% | 10,950 | – | – |
|
277
Roku
ROKU
$14.2B
| $1.06M | ﹤0.01% | 16,500 -34,800 | -68% | -$2.24M |
|
278
Adient
ADNT
$2.01B
| $953K | ﹤0.01% | 73,520 | – | – |
|
279
Garrett Motion
GTX
$2.62B
| $724K | ﹤0.01% | 49,158 | – | – |
|
280
Johnson & Johnson
JNJ
$427B
| $657K | ﹤0.01% | 4,700 -11,600 | -71% | -$1.62M |
|
281
RB Global
RBA
$21.3B
| $530K | ﹤0.01% | 15,583 -2,524,692 | -99% | -$85.9M |
|
282
Performance Food Group
PFGC
$15.9B
| $440K | ﹤0.01% | 11,100 | – | – |
|
283
Greif
GEF
$3.8B
| – | – | -45,000 | Closed | -$1.67M |
|
284
Salarius Pharmaceuticals
SLRX
$2.94M
| – | – | -38,500 | Closed | -$13K |
|
|
MB
285
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| – | – | -160,577 | Closed | -$5.85M |
|